Amoy Diagnostics (300685.SZ) stated on the investor platform that the company's overseas market is currently focused on East Asia, Europe, Southeast Asia, and other markets. The company's production and operation have been stable and orderly, and the management will continue to do a good job in various tasks such as operation and management, insisting on sustainable and profitable growth, and creating value for society and shareholders.
艾德生物(300685.SZ)：公司海外市场聚焦在东亚、欧洲及东南亚等市场
Amoy Diagnostics (300685.SZ): The company's overseas markets focus on East Asia, Europe, Southeast Asia and other markets.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.